ImmunityBio Inc (IBRX)
8.12
+0.06
(+0.74%)
USD |
NASDAQ |
May 10, 16:00
8.03
-0.09
(-1.11%)
After-Hours: 20:00
ImmunityBio Shareholders Equity (Quarterly): -586.99M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -586.99M |
| September 30, 2023 | -411.72M |
| June 30, 2023 | -642.12M |
| March 31, 2023 | -528.98M |
| December 31, 2022 | -447.33M |
| September 30, 2022 | -426.70M |
| June 30, 2022 | -419.82M |
| Date | Value |
|---|---|
| March 31, 2022 | -335.64M |
| December 31, 2021 | -242.17M |
| September 30, 2021 | -188.50M |
| June 30, 2021 | -157.94M |
| March 31, 2021 | -185.79M |
| December 31, 2020 | -119.81M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-642.12M
Minimum
Jun 2023
-119.81M
Maximum
Dec 2020
-361.04M
Average
-411.72M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 544.91M |
| iBio Inc | 9.197M |
| Lixte Biotechnology Holdings Inc | 3.995M |
| Abeona Therapeutics Inc | 14.83M |
| Chromocell Therapeutics Corp | -5.905M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 504.45M |
| Total Liabilities (Quarterly) | 1.090B |
| Debt to Equity Ratio | -1.161 |
| Current Ratio | 5.046 |
| Net Debt Paydown Yield | -0.12% |